98%
921
2 minutes
20
RNA-binding proteins play crucial roles in various RNA-associated biological processes, which are closely linked to cellular function and disease. Based on CLIP-seq data, the existing deep learning methods are developed to predict protein-RNA interactions. However, CLIP-seq relies on gene expression, which varies significantly across cells. Existing methods are typically trained on peak-associated binding sites and implicitly defined non-binding sites, without considering the cell-specific expression profiles. Given the dynamic nature of protein-RNA interactions, these methods struggle to accurately predict the binding nucleotides and strength of proteins on RNAs across cell lines. Therefore, this study proposes a novel deep learning-based method, iDeepB, designed to predict the proteins binding profile on RNAs at base resolution by integrating cell-line-specific gene expression profiles. iDeepB first constructs expression-aware benchmark datasets based on cell-specific RNA-seq and eCLIP-seq data, which is used to train a hybrid deep network with multi-head attention, enabling the prediction of protein binding profiles, analysis of binding motif syntax composition, and quantification of functional effects of genome mutations related to human diseases. Comprehensive evaluation on the newly developed benchmark datasets demonstrates that iDeepB outperforms existing methods in predicting protein binding profile on RNAs.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12341914 | PMC |
http://dx.doi.org/10.1093/nar/gkaf748 | DOI Listing |
Exp Neurobiol
August 2025
Institute of Medical Science, Ajou University School of Medicine, Suwon 16499, Korea.
Neural tumors represent diverse malignancies with distinct molecular profiles and present particular challenges due to the blood-brain barrier, heterogeneous molecular etiology including epigenetic dysregulation, and the affected organ's critical nature. KCC-07, a selective and blood-brain barrier penetrable MBD2 (methyl CpG binding domain protein 2) inhibitor, can suppress tumor development by inducing p53 signaling, proven only in medulloblastoma. Here we demonstrate KCC-07 treatment's application to other neural tumors.
View Article and Find Full Text PDFBiochem Pharmacol
September 2025
Department of Biosciences, JIS University, 81, Nilgunj Road, Agarpara, Kolkata, West Bengal 700109, India. Electronic address:
The malignant manifestation of breast cancer is driven by complex molecular alterations that extend beyond genetic mutations to include epigenetic dysregulation. Among these, DNA methylation is a critical and reversible epigenetic modification that significantly influences breast cancer initiation, progression, and therapeutic resistance. This process, mediated by DNA methyltransferases (DNMTs), involves the addition of methyl groups to cytosine residues within CpG dinucleotides, resulting in transcriptional repression of genes.
View Article and Find Full Text PDFEcotoxicol Environ Saf
September 2025
Department of Urology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China. Electronic address:
Background: Prostate cancer (PRAD) is a common malignancy in men, and exposure to soil pollutants may contribute to its development. And exposure to soil pollutant has been linked to its development, as well as to other diseases including cardiovascular disorders, neurological conditions, and additional cancers.
Methods: This study integrates network toxicology, machine learning, and advanced technologies to investigate the mechanisms through which soil pollutants affect prostate cancer.
Blood
September 2025
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Isatuximab is an IgG1k monoclonal antibody that binds with high affinity to CD38 expressed on plasma cells. Anti-CD38 antibodies have shown efficacy as monotherapy and in combination in a variety of settings for patients with multiple myeloma and light chain (AL) amyloidosis. This multi-center, cooperative group phase 2 trial was designed to evaluate hematologic response, organ response, and safety of isatuximab monotherapy for the treatment of relapsed AL amyloidosis.
View Article and Find Full Text PDFChem Biodivers
September 2025
Department of Clinical Pharmacy, College of Pharmacy, University of Sulaimani, Sulaimani, Iraq.
The global rise in antibiotic resistance demands the urgent development of new antibacterial agents. This study investigated the antibacterial potential of four synthesized methoxy and thiophene chalcone derivatives (designated 3a, 4a, 3b, and 4b) against clinically relevant bacterial pathogens. These compounds were prepared through Claisen-Schmidt condensation, while their chemical structures were verified through applying Fourier-transform infrared, mass spectrometry, H nuclear magnetic resonance (NMR), and C NMR.
View Article and Find Full Text PDF